Published in Circ J on December 28, 2012
Learning from the Cardiologists and Developing Eluting Stents Targeting the Mtor Pathway for Pulmonary Application; A Future Concept for Tracheal Stenosis. J Mol Genet Med (2013) 0.78
Impact of sirolimus-eluting stent fractures without early cardiac events on long-term clinical outcomes: a multislice computed tomography study. Eur Radiol (2014) 0.77
Stretchable active-matrix organic light-emitting diode display using printable elastic conductors. Nat Mater (2009) 3.66
IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis. J Immunol (2005) 3.02
Anticoagulant therapy for idiopathic pulmonary fibrosis. Chest (2005) 3.02
Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease. Circulation (2002) 3.01
Coronary restenosis after sirolimus-eluting stent implantation: morphological description and mechanistic analysis from a consecutive series of cases. Circulation (2003) 3.01
Noncardiac findings in cardiac imaging with multidetector computed tomography. J Am Coll Cardiol (2006) 2.86
Compensatory proliferation in Drosophila imaginal discs requires Dronc-dependent p53 activity. Curr Biol (2006) 2.51
Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry. Circulation (2003) 2.31
Malignant peripheral nerve sheath tumor arising from benign vestibular schwannoma treated by gamma knife radiosurgery after two previous surgeries: a case report with surgical and pathological observations. World Neurosurg (2010) 2.09
Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol (2005) 2.00
Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis. Radiology (2006) 1.95
Incidence and clinical impact of coronary stent fracture after sirolimus-eluting stent implantation. Catheter Cardiovasc Interv (2007) 1.88
In vivo intravascular ultrasound-derived thin-cap fibroatheroma detection using ultrasound radiofrequency data analysis. J Am Coll Cardiol (2005) 1.85
The effect of variable dose and release kinetics on neointimal hyperplasia using a novel paclitaxel-eluting stent platform: the Paclitaxel In-Stent Controlled Elution Study (PISCES). J Am Coll Cardiol (2005) 1.67
Sirolimus-eluting stents remain superior to bare-metal stents at two years: medium-term results from the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry. J Am Coll Cardiol (2006) 1.57
Accumulation of p62/SQSTM1 is associated with poor prognosis in patients with lung adenocarcinoma. Cancer Sci (2012) 1.54
Human autopsy study of drug-eluting stents restenosis: histomorphological predictors and neointimal characteristics. Eur Heart J (2013) 1.54
Sirolimus-eluting stent for treatment of complex in-stent restenosis: the first clinical experience. J Am Coll Cardiol (2003) 1.53
Vascular response to drug-eluting stent with biodegradable vs. durable polymer. Optical coherence tomography substudy of the NEXT. Circ J (2014) 1.52
Efficacy of everolimus eluting stent implantation in patients with calcified coronary culprit lesions: two-year angiographic and three-year clinical results from the SPIRIT II study. Catheter Cardiovasc Interv (2010) 1.51
Applicability of enhanced recovery program for advanced liver surgery. World J Surg (2014) 1.48
Geometrical validation of intravascular ultrasound radiofrequency data analysis (Virtual Histology) acquired with a 30 MHz boston scientific corporation imaging catheter. Catheter Cardiovasc Interv (2005) 1.46
Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up. Circulation (2002) 1.46
One-year clinical outcome after coronary stenting of very small vessels using 2.25 mm sirolimus- and paclitaxel-eluting stents: a comparison between the RESEARCH and T-SEARCH registries. J Invasive Cardiol (2005) 1.44
Two-stage pancreatojejunostomy in pancreaticoduodenectomy: a retrospective analysis of short-term results. Am J Surg (2008) 1.41
Characterization of edge effects with paclitaxel-eluting stents using serial intravascular ultrasound radiofrequency data analysis: the BETAX (BEside TAXus) Study. Rev Esp Cardiol (2008) 1.41
Effectiveness of the sirolimus-eluting stent in the treatment of saphenous vein graft disease. J Invasive Cardiol (2004) 1.41
Sirolimus-eluting stents suppress neointimal formation irrespective of metallic allergy. Circ J (2008) 1.41
Three-year clinical outcomes after coronary stenting of chronic total occlusion using sirolimus-eluting stents: insights from the rapamycin-eluting stent evaluated at Rotterdam cardiology hospital-(RESEARCH) registry. Catheter Cardiovasc Interv (2007) 1.40
Elective sirolimus-eluting stent implantation for multivessel disease involving significant LAD stenosis: one-year clinical outcomes of 99 consecutive patients--the Rotterdam experience. Catheter Cardiovasc Interv (2004) 1.40
The impact of cutting balloon angioplasty for the treatment of diffuse in-stent restenosis. J Invasive Cardiol (2003) 1.39
Ectopic recurrence of craniopharyngioma. J Clin Neurosci (2005) 1.39
A new 0.010-inch guidewire and compatible balloon catheter system: the IKATEN registry. Catheter Cardiovasc Interv (2009) 1.39
Sirolimus-eluting stents for the treatment of atherosclerotic ostial lesions. J Invasive Cardiol (2005) 1.39
Paclitaxel eluting stents for the treatment of angiographically non-significant atherosclerotic lesions. Int J Cardiovasc Intervent (2005) 1.38
Identification of pendrin as a common mediator for mucus production in bronchial asthma and chronic obstructive pulmonary disease. J Immunol (2008) 1.30
Has our understanding of calcification in human coronary atherosclerosis progressed? Arterioscler Thromb Vasc Biol (2014) 1.27
Efficacy of culprit plaque assessment by 64-slice multidetector computed tomography to predict transient no-reflow phenomenon during percutaneous coronary intervention. Am Heart J (2008) 1.25
Classification and potential mechanisms of intravascular ultrasound patterns of stent fracture. Am J Cardiol (2009) 1.23
Biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent: a randomized, controlled, noninferiority trial. J Am Coll Cardiol (2013) 1.23
Basic helix-loop-helix protein DEC1 promotes chondrocyte differentiation at the early and terminal stages. J Biol Chem (2002) 1.23
Minimum apparent diffusion coefficient is significantly correlated with cellularity in medulloblastomas. Neurol Res (2009) 1.21
The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population: one-year results of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry. J Am Coll Cardiol (2005) 1.21
Long-term outcomes after stenting of bifurcation lesions with the "crush" technique: predictors of an adverse outcome. J Am Coll Cardiol (2006) 1.20
Why is the mammary artery so special and what protects it from atherosclerosis? Ann Cardiothorac Surg (2013) 1.20
Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes: insights from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry. J Am Coll Cardiol (2003) 1.18
Acute pancreatitis due to pancreatic arteriovenous malformation: 2 case reports and review of the literature. Pancreas (2006) 1.16
Comparison of everolimus-eluting and sirolimus-eluting coronary stents: 1-year outcomes from the Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting stent Trial (RESET). Circulation (2012) 1.16
Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH Registries). Am J Cardiol (2007) 1.14
Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: results from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial. J Am Coll Cardiol (2009) 1.12
Restenosis rates following bifurcation stenting with sirolimus-eluting stents for de novo narrowings. Am J Cardiol (2004) 1.11
Clinical and pathologic characteristics of dilated cardiomyopathy in hemodialysis patients. Kidney Int (2005) 1.11
Runx2 in human breast carcinoma: its potential roles in cancer progression. Cancer Sci (2010) 1.11
Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer. Int J Cancer (2013) 1.11
Glomangiopericytoma of the nasal cavity. Auris Nasus Larynx (2010) 1.10
Long-term survivors of glioblastoma: clinical features and molecular analysis. Acta Neurochir (Wien) (2009) 1.08
Relationship between serum 1,25-dihydroxyvitamin D and mortality in patients with pre-dialysis chronic kidney disease. Clin Exp Nephrol (2008) 1.08
5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents. J Am Coll Cardiol (2009) 1.07
IL-17A promotes the growth of airway epithelial cells through ERK-dependent signaling pathway. Biochem Biophys Res Commun (2006) 1.07
Total-circumference intraoperative frozen section analysis reduces margin-positive rate in breast-conservation surgery. Jpn J Clin Oncol (2010) 1.07
Optimum selection of an implantable secondary battery for an artificial heart by examination of the cycle life test. ASAIO J (2002) 1.06
Are Microcalcification and Hemosiderin Really Limitations of OCT in Detection of TCFA? JACC Cardiovasc Imaging (2016) 1.06
Radiologic-pathologic correlation of ductal carcinoma in situ. Radiographics (2010) 1.04
Angiomyolipoma in the knee--a case report. Ups J Med Sci (2005) 1.02
Cohort study of the survival benefit of resection for recurrent hepatic and/or pulmonary metastases after primary hepatectomy for colorectal metastases. Ann Surg (2010) 1.02
Long-term follow-up of incomplete stent apposition in patients who received sirolimus-eluting stent for de novo coronary lesions: an intravascular ultrasound analysis. Circulation (2003) 1.02
Hemorrhagic onset of pilocytic astrocytoma and pilomyxoid astrocytoma. Brain Tumor Pathol (2009) 1.01
Increased expression of serum Matrix Metalloproteinase-9 in patients with moyamoya disease. Surg Neurol (2009) 0.99
Hexokinase II in breast carcinoma: a potent prognostic factor associated with hypoxia-inducible factor-1α and Ki-67. Cancer Sci (2013) 0.99
Elevated risk of colorectal adenoma with Helicobacter pylori-related chronic gastritis: a population-based case-control study. Int J Cancer (2011) 0.99
Combined therapy after superselective arterial cisplatin infusion to treat maxillary squamous cell carcinoma. Otolaryngol Head Neck Surg (2007) 0.99
Lipofibromatosis arising in a pediatric forearm--a case report. Ups J Med Sci (2005) 0.99
Recovery of liver function after the cessation of preoperative chemotherapy for colorectal liver metastasis. Ann Surg Oncol (2010) 0.99
Planning of anatomical liver segmentectomy and subsegmentectomy with 3-dimensional simulation software. Am J Surg (2013) 0.98
Enantioselective 1,3-dipolar cycloaddition reaction between diazoacetates and alpha-substituted acroleins: total synthesis of manzacidin A. J Am Chem Soc (2006) 0.98
Intramedullary spinal tuberculoma--case report. Neurol Med Chir (Tokyo) (2004) 0.98
Low-grade fibromyxoid sarcoma of intracranial origin. J Neurosurg (2008) 0.97
Vascular responses at proximal and distal edges of paclitaxel-eluting stents: serial intravascular ultrasound analysis from the TAXUS II trial. Circulation (2004) 0.96
Hypophysitis presenting with atypical rapid deterioration: with special reference to immunoglobulin G4-related disease-case report-. Neurol Med Chir (Tokyo) (2009) 0.96
Newly synthesized curcumin analog has improved potential to prevent colorectal carcinogenesis in vivo. Cancer Sci (2009) 0.96
Luminal-type breast cancer: correlation of apparent diffusion coefficients with the Ki-67 labeling index. Radiology (2014) 0.96
Somatostatin receptor subtypes in human non-functioning neuroendocrine tumors and effects of somatostatin analogue SOM230 on cell proliferation in cell line NCI-H727. Anticancer Res (2007) 0.96
IDH1/2 gene status defines the prognosis and molecular profiles in patients with grade III gliomas. Int J Clin Oncol (2011) 0.95
Clinical usefulness of KRAS, BRAF, and PIK3CA mutations as predictive markers of cetuximab efficacy in irinotecan- and oxaliplatin-refractory Japanese patients with metastatic colorectal cancer. Int J Clin Oncol (2012) 0.94
Hypoglossal neurinoma presenting with intratumoral hemorrhage. J Clin Neurosci (2002) 0.94